Clinical Trials Directory

Trials / Sponsors / Nanjing Zenshine Pharmaceuticals

Nanjing Zenshine Pharmaceuticals

Industry · 15 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients
Advanced Solid Tumors
Phase 12025-12-26
CompletedStudy to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to
Respiratory Viral Infection
Phase 32025-10-13
CompletedStudy to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Ma
Respiratory Viral Infection
Phase 12025-02-20
TerminatedStudy to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
Respiratory Viral Infection
Phase 32024-10-31
CompletedStudy to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza
Respiratory Viral Infection
Phase 32023-11-30
CompletedA Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Ad
Drug Interaction
Phase 12023-08-28
CompletedA Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects
Influenza, Human
Phase 12023-07-08
CompletedA Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy A
Pharmacokinetics
Phase 12023-07-02
CompletedPharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects
Influenza, Human
Phase 12023-04-12
CompletedSubstance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China
Influenza, Human
Phase 12023-02-14
CompletedA Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza
Influenza, Human
Phase 2 / Phase 32022-07-17
UnknownA Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors
Advanced Solid Tumor
Phase 1 / Phase 22022-03-09
CompletedA Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignan
Non Hodgkin Lymphoma, Peripheral T Cell Lymphoma, CLL/SLL
Phase 1 / Phase 22022-02-17
UnknownDose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Phase 12022-01-03
CompletedStudy to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volun
Safety Issues, Tolerance, Pharmacokinetics
Phase 12021-12-01